February 28, 2018 5:51pm

... Until the algorithms fried the incline erasing many gains

As the IBB (-1.83%), XLV (-1.60%) as the XBI (-1.81%) dived and the NASDAQ (-0.78%) crumbled

And volume is still weak

 

Pre-open indication results: 7 hits and 1 miss

Out and about: AxoGen (AXGN -$2.00) slips pre-earnings release; MiMedx Group (MDXG -$0.18) dives again in a day’s range of $7.09 to $7.48 with 3 M shares traded versus yesterday’s 7.92 M <3 month average = 2.93 M shares> to close at $7.09 after yesterday’s $7.27.

 

Why spend time finding sector news and analytics – it’s all right here; review daily indicators, factors and trend lines, advance/decline lines of 40 covered companies, pre-open indicator results, volatility and of the % count of decliners versus gainers with a few surprises in the shifting sands of appreciation or depreciation


 

Wednesday’s results have implications to Thursday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

 

Henry’omics:

From the pre-open’s newsletter, “…short-term sector weakness follows strength. The weakness is usually followed by the oversold being recognized who then will progress to being the overbought. Sector rotation is hot one-day and the loser the next and we are now in the midst of quarterly financial results AKA earnings.”

February was a volatile month for stocks. The major averages dipped in correction territory earlier this month, falling 10% from record highs set on 1/26. The move lower came as fears of rising inflation sent rates higher and sent market volatility surging after a year of unprecedented calm.

Market caps keep getting stretched …

Sector volatility is being caused by one overarching theme: expectation and/or the lack thereof!

Facts and truth matter as pricing is related to transparency with guidance thrown in for effect …

 

 

The advance/decline line scenario of 40 SCGT & RT covered companies:   

  • The open was barely positive with an A/DL of 19/17 and 4 flat ;
  • The mid-day continued positive the A/DL to 24/10 and 4 flats;
  • The close was negative with an A/DL of 14/25 and 1 flat;

 

Pre-open indication results:  7 hits and 1 miss

  • AxoGen (AXGN) closed down -$2.00 – hit;
  • bluebird bio (BLUE) closed down -$2.15 – hit;
  • Fate Therapeutics (FATE) closed down -$0.24 – hit;
  • Caladrius Bioscience (CLBS) closed down -$0.01 – hit;
  • Mesoblast (MESO) closed up +$0.38 – hit;
  • MiMedx (MDXG) closed down -$0.18 – miss;
  • Sangamo Therapeutics (SGMO) closed up +$0.50 – hit;
  • Vericel (VCEL) closed down -$0.25 – hit;

 

 

The shifting sands of appreciation and depreciation:

The come-back sector stocks: Monday’ADVM (+$0.125 after +$0.15 post Monday’s -$0.30), AGTC (+$0.20 after -$0.10 after Monday'ss $0.00), 

Surprised: CAPR (+$0.05 after -$0.02 post Monday’s -$0.03 – needs a financing)

Falling from the high wire: BLUE (-$2.15 after +$2.00 after Monday’s-$4.90), FATE (-$0.24 after -$0.56 post Monday’s +0.30), CLLS (-$0.51 after -$0.50 post Monday’s -$0.20),

Undervalued – needs news: HSGX (-$0.02 after -$0.02 post Monday’s +$0.03), VSTM (-$0.14 after -$0.01 post Monday’s +$0.01), AST (-$0.05 after -$0.05 post Monday’s +$0.05),

While the downers: AXGN (-$2.00, after +$1.70 and Monday’s $0.55), ADRO (-$0.05 after -$0.25 post Monday’s -$0.05), CLBS (-$0.01 after +$0.22 post Monday’s +$0.28), PSTI (-$0.02 after +$0.08 post Monday’s -$0.01)

The non-gift that keeps on dipping: ONVO (-$0.01 after-$0.03 post Monday’s +$0.04),

Not surprised by: VCEL (-$0.15 after +$0.15 after Monday’s+$0.80), ATHX (-$0.07 after +$0.06 post Monday’s -$0.02), MESO (+$0.38 after -$0.42), OSIR (+$0.31 after -$0.22 post Monday’s -$0.45), BLCM (-$0.37 after +$0.04 post Monday’s +$0.25),

In the last hour: QURE (-$0.08 after -$0.21 post Monday’s +$0.21), STML (+$0.15 after -$0.55 post Monday’s -$0.20), BSTG (+$0.29 – still my opinion, fraud), FCSC (-$0.051 after +$0.026 post Monday’s +$0.03), KOOL (-$0.07 after -$0.02 post Monday’s -$0.01 – on news)

Trading games: BCLI (+$0.03 after +$0.02 post Monday’s +$0.02) and NWBO (+$0.001 after +$0.003 post Monday’s +$0.002)

 

 

MY working trend lines:

The greatest volume to the downside:  MDXG, XON, VCEL, FCSC and BLCM

Upside volume was weighted to:  SGMO, ADVM, JUNO, NWBO and MESO

Biggest $ downside:  BLUE (-$2.15), AXGN (-$2.00), ONCE (-$1.14), RGNX (-$0.75) and CLLS (-0.51)

Largest $ upside:  SGMO (+$0.50), MESO (+$0.38), OSIR (+$0.31), BSTG (+40.29) and AGTC (+$0.20)

Flat: RENE.L

 

 

Daily analytics:

U.S. stocks closed lower in a volatile session Wednesday, reversing their earlier gains as Wall Street digested data that were seen as underlining the economy’s robust health, although that same strength could warrant the Federal Reserve to turn more hawkish and increase corporate borrowing costs.

  • The Dow skidded 380.83 points, or 1.5%, to 25,029.20.
  • The S&P 500 index shed 30.45 points, or 1.1%, to 2,731.83.
  • The NASDAQ lost 57.35 points, or 0.8%, to 7,273.01, falling 1.9% for the month.

 

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market,

  • Wednesday traded at 19.84, up +6.72% …
  • Tuesday traded at 18.59, up +17.66% …
  • Monday traded at 15.80, down -4.18% …
  • Friday traded at 16.64, down -11.11% …
  • Thursday traded at 18.72, down -6.49% …
  • Last Wednesday traded at 20.22, down -2.82% …

 

The iShares Russell 2000 (IWM) indicated:

  • Wednesday was down -1.53%
  • Tuesday -1.45%
  • Monday +0.64%
  • Friday +1.30%
  • Thursday -0.15%
  • Last Wednesday +0.09%

 

The iShares NASDAQ Biotechnology (IBB) indicated:

  • Wednesday was down -1.83%
  • Tuesday -1.25%
  • Monday +0.73%
  • Friday +2.08%
  • Thursday -0.61%
  • Last Wednesday -0.16%

 

 

The count - decliners versus gainers:

……. look at the differences in decliners:

  • Wednesday’s decliners ranged from -0.21% <CLBS -$0.01> to -6.41% <AXGN -$2.00> in 25 equities;
  • Tuesday’s decliners ranged from -0.31% <VSTM -$0.01> to -6.01%% <SGMO -$1.50> in 24 equities;
  • Monday’s decliners ranged from -0.51% <RENE.L -$0.50> to -6.13% <MDXG -$0.48> in 17 equities;
  • Friday’s decliners ranged from -0.34% <CLLS -$0.11> to -11.82% <MDXG -$1.05> in 17 equities;
  • Thursday’s decliners ranged from -0.09% <JUNO -$0.08> to -8% <FCSC -$0.053> in 10 equities;
  • Last Wednesday’s decliners ranged from -0.15% <BSTG -$0.00> to -10.63% <RENE.L> in 13 equities;

Versus

… Look at the percentage’s (%) and spreads …

  • Wednesday’s gainers ranged from +0.16% <JUNO +$0.14> to +9.63% <BSTG +$0.29> in 14 equities;
  • Tuesday’s gainers ranged from +0.03% <JUNO +$0.03> to +5.84% <PSTI +$0.08> in 15 equities;
  • Monday’s gainers ranged from +0.02% <JUNO +$0.02> to +17.93% <MESO +$1.11> in 20 equities;
  • Friday’s gainers ranged from +0.02% <JUN) +$0.02> to +11.15% <FATE +$1.18> in 21 equities;
  • Thursday’s gainers ranged from +0.15% <CLLS +$0.05> to +14.41% <SGMO +$3.20> in 28 equities;
  • Last Wednesday’s gainers ranged from +0.08% <XON +0.01> to +15.49% <FATE +$1.42> in 24 equities;

 

                                  

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.